River Reporter
In the River Reporter, Pennsylvania patient advocate Veronica C. argued that policymakers should focus on transparency in federal drug pricing programs to ensure patients actually benefit from the discounts intended to help them. Veronica warned that proposals like Most Favored Nation (MFN) pricing could slow medical innovation and limit access to new treatments.